Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/11981
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Leung, Christopher | - |
dc.contributor.author | Herath, Chandana B | - |
dc.contributor.author | Jia, Zhiyuan | - |
dc.contributor.author | Goodwin, Michelle | - |
dc.contributor.author | Mak, Kai Yan | - |
dc.contributor.author | Watt, Matthew J | - |
dc.contributor.author | Forbes, Josephine M | - |
dc.contributor.author | Angus, Peter W | - |
dc.date.accessioned | 2015-05-16T01:36:59Z | |
dc.date.available | 2015-05-16T01:36:59Z | |
dc.date.issued | 2013-12-06 | - |
dc.identifier.citation | Journal of Hepatology 2013; 60(4): 832-8 | en_US |
dc.identifier.other | PUBMED | en |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/11981 | en |
dc.description.abstract | Advanced glycation end-products (AGEs) levels are high in western diets and contribute to tissue injury via activation of RAGE (receptor for AGEs) and generation of reactive oxygen species (ROS). Here, we determined if high dietary AGE intake worsens progression of non-alcoholic fatty liver disease (NAFLD).Male Sprague Dawley rats were fed a methionine choline deficient (MCD) diet for 6 weeks before 6 weeks of a high AGE MCD diet through baking. They were compared with animals on MCD diet or a methionine choline replete (MCR) diet alone for 12 weeks. Hepatic ROS, triglycerides, biochemistry, picro-sirius morphometry, hepatic mRNA expression and immunohistochemistry were determined. Primary hepatic stellate cells (HSCs) from both MCR and MCD animals were exposed to AGEs. ROS, proliferation and mRNA expression were determined.The high AGE MCD diet increased hepatic AGE content and elevated triglycerides, NADPH dependent superoxide production, HNE adducts, steatosis, steatohepatitis (CD43, IL-6, TNF-α) and fibrosis (α-SMA, CTGF, COL1A, picrosirius) compared to MCD alone. In HSCs, AGEs significantly increased ROS production, bromodeoxyuridine proliferation and MCP-1, IL-6, α-SMA, and RAGE expression in HSCs from MCD but not MCR animals. These effects were abrogated by RAGE or NADPH oxidase blockade.In the MCD model of NAFLD, high dietary AGEs increases hepatic AGE content and exacerbates liver injury, inflammation, and liver fibrosis via oxidative stress and RAGE dependent profibrotic effects of AGEs on activated HSCs. This suggests that pharmacological and dietary strategies targeting the AGE/RAGE pathway could slow the progression of NAFLD. | en_US |
dc.language.iso | en | en |
dc.subject.other | Advanced glycation end-products | en |
dc.subject.other | Hepatic stellate cell | en |
dc.subject.other | Non-alcoholic fatty liver disease | en |
dc.subject.other | Oxidative stress | en |
dc.subject.other | Steatohepatitis | en |
dc.subject.other | Animals | en |
dc.subject.other | Cell Proliferation | en |
dc.subject.other | Choline Deficiency.complications | en |
dc.subject.other | Diet.adverse effects | en |
dc.subject.other | Disease Progression | en |
dc.subject.other | Gene Expression | en |
dc.subject.other | Glycosylation End Products, Advanced.administration & dosage.metabolism.toxicity | en |
dc.subject.other | Hepatic Stellate Cells.metabolism.pathology | en |
dc.subject.other | Insulin Resistance | en |
dc.subject.other | Liver.metabolism.pathology | en |
dc.subject.other | Male | en |
dc.subject.other | Methionine.deficiency | en |
dc.subject.other | Non-alcoholic Fatty Liver Disease.etiology.metabolism.pathology | en |
dc.subject.other | Oxidative Stress | en |
dc.subject.other | Rats | en |
dc.subject.other | Rats, Sprague-Dawley | en |
dc.title | Dietary glycotoxins exacerbate progression of experimental fatty liver disease. | en_US |
dc.type | Journal Article | en_US |
dc.identifier.journaltitle | Journal of Hepatology | en_US |
dc.identifier.affiliation | Medicine (University of Melbourne) | en_US |
dc.identifier.affiliation | Gastroenterology and Hepatology | en_US |
dc.identifier.affiliation | Glycation and Diabetes Complications Group, Mater Medical Research Institute, South Brisbane, Queensland, Australia | en_US |
dc.identifier.affiliation | Glycation and Diabetes Group, Baker IDI Diabetes Institute, Melbourne, Victoria, Australia | en_US |
dc.identifier.affiliation | Department of Physiology, Monash University, Clayton, Victoria, Australia | en_US |
dc.identifier.doi | 10.1016/j.jhep.2013.11.033 | en_US |
dc.description.pages | 832-8 | en |
dc.relation.url | https://pubmed.ncbi.nlm.nih.gov/24316518 | en |
dc.type.content | Text | en_US |
dc.type.austin | Journal Article | en |
local.name.researcher | Angus, Peter W | |
item.grantfulltext | none | - |
item.openairetype | Journal Article | - |
item.languageiso639-1 | en | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Gastroenterology and Hepatology | - |
crisitem.author.dept | University of Melbourne Clinical School | - |
crisitem.author.dept | Clinical Education | - |
crisitem.author.dept | Medicine (University of Melbourne) | - |
crisitem.author.dept | Victorian Liver Transplant Unit | - |
crisitem.author.dept | Gastroenterology and Hepatology | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.